Alvir, J., Lieberman, J., Safferman, A., et al (1993) Clozapine induced agranulocytosis – incidence and risk factors in the United States. New England Medical Journal, 329, 204–205.
Anderson, C. (1983) A psychoeducational model of family treatment for schizophrenia. In Psychosocial Intervention in Schizophrenia (eds Stierlin, H., Wynne, L. C. & Wirsching, M.), pp. 227–235. New York: Springer Verlag.
Atkin, K. (1994) Clozapine induced neutropenia or not?
British Journal of Psychiatry, 165, 407–408.
Biederman, J., Lerner, Y. & Belmaker, R. H. (1979) Combination of lithium carbonate in schizoaffective disorder. Archives of General Psychiatry, 36, 327–333.
Birchwood, M., McMillan, J. F. & Smith, J. (1992) Early intervention. In Innovations in the Psychological Management of Schizophrenia (eds Birchwood, M. & Tarrier, N.). Chichester: Wiley.
Birchwood, M. & Shepherd, G. (1992) Controversies and growing points in cognitive behavioural interventions for people with schizophrenia. Psychotherapy, 20, 305–342.
Bratfos, O. & Haug, J. O. (1979) Comparison of sulpiride and chlorpromazine in psychoses, a double blind multicentre trial. Acta Psychiatrica Scandinavica, 60, 1–9.
Brenner, H. D., Dencker, S. J., Goldstein, M., et al (1990) Defining treatment refractoriness in schizophrenia. Schizophrenia Bulletin, 16, 551–561.
Carman, J. S., Bigelow, L. B. & Wyatt, R. J. (1981) Lithium combined with neuroleptics in chronic schizophrenia and schizoaffective patients. Journal of Clinical Psychiatry, 42, 124–128.
Cohen, N. J. & Cohen, N. H. (1974) Lithium carbonate, haloperidol and irreversible brain damage. Journal of the American Medical Association, 230, 1283–1287.
Falloon, I. R. H., Boyd, J. L., McGill, C. W., et al (1982) Family management in the prevention of exacerbations of schizophrenia. New England Journal of Medicine, 306, 1437–1440.
Falloon, I. R. H. & Shanahan, W. J. (1990) Community management of schizophrenia. British Journal of Hospital Medicine, 43, 62–66.
Farmer, A. E. & Blewett, A. (1993) Drug treatment of resistant schizophrenia. Limitations and recommendations. Drug, 45, 374–383.
Fischer-Kornelsson, K. A. & Ferner, U. J. (1976) An example of European multicentre trials: multispectral analysis of clozapine. Psychopharmacology Bulletin, 12, 34–39.
Gerlach, J., Koppelhus, P., Helweg, E., et al (1974) Clozapine and haloperidol in a single blind crossover trial. Therapeutic and biochemical aspects in the treatment of schizophrenia. Acta Psychiatrica Scandinavica, 50, 410–424.
Herz, M. I., Glazer, W., Mirza, M., et al (1989) Treating prodromal episodes to prevent relapse in schizophrenia. British Journal of Psychiatry, 155, 123–127.
Honigfeld, G. & Patin, J. (1990) A two year clinical and economic follow up of patients and clozapine. Hospital and Community Psychiatry, 41, 882–885,
Huckle, P. L. & Palia, S. S. (1993) Managing resistant schizophrenia. British Journal of Hospital Medicine, 50, 467–471.
Kane, J. M. (1992) Clinical efficacy of clozapine in treatment refractory schizophrenia: an overview. British Journal of Psychiatry, 160 (Suppl. 17), 41–45.
Kane, J. M., Honigfeld, G., Singer, J., et al (1988) Clozapine for the treatment resistant schizophrenic: a double blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 789–796.
Kane, J. M., Honigfeld, G., Singer, J., et al (1990) Is clozapine response different in neuroleptic non-responders vs partial responders: in reply. Archives of General Psychiatry, 47, 189–190.
Kuehnel, T. C., Liberman, R. P., Marshall, B. D., et al (1992) Optimal drug and behaviour therapy for treatment-refractory, institutionalised schizophrenics. In Effective Psychiatric Rehabilitation: New Directions for Mental Illness Services (ed. Liberman, R.), pp. 67–77. San Francisco: Josey Bass.
Lader, M. (1994) Does Clozaril improve the cognitive and psychomotor function of schizophrenic patients?
Clozaril Newsletter, 8, 1–3.
Levinson, D. F. (1991) Pharmacologic treatment of schizophrenia. Clinical Therapeutics, 13, 326–352.
Lindstrom, L. H. (1988) The effect of long term treatment with clozapine in schizophrenia: a retrospective study in 96 patients treated with clozapine for up to 13 years. Acta Psychiatrica Scandinavica, 77, 524–529.
Marder, S. R. & Van Putten, T. (1988) Who should receive clozapine?
Archives of General Psychiatry, 45, 865–867.
Meltzer, H. Y. (1992) Treatment of the neuroleptic, non-responsive schizophrenic patient. Schizophrenic Bulletin, 18, 515–542.
Meltzer, H. Y., Burnett, S., Bastina, B., et al (1990) Effects of 6 months of clozapine treatment on the quality of life in chronic schizophrenic patients. Hospital and Community Psychiatry, 41, 892–897.
Muijen, M. (1994) Rehabilitation and care of the mentally ill. Current Opinion in Psychiatry, 7, 202–206.
Muijen, M., Marks, I. M., Connolly, J., et al (1992) The Daily Living Programme: preliminary comparison of community versus hospital-based treatment for the seriously mentally ill facing emergency admission. British Journal of Psychiatry, 160, 379–384.
Osser, D. N. (1989) A systematic approach to pharmacotherapy in patients with neuroleptic resistant psychoses. Hospital and Community Psychiatry, 40, 921–927.
Peroutka, S. J. & Snyder, S. H. (1980) Relationship of neuroleptic drug effects on brain dopamine, serotonin, alpha-adrenergic and histamine receptors to clinical potency. American Journal of Psychiatry, 137, 1518–1519.
Pickar, D., Owen, R. R., Litman, R. E., et al (1992) Clinical and biologic response to clozapine in patients with schizophrenia. Archives of General Psychiatry, 49, 345–353.
Small, J., Kelloms, J. J., Milstein, V., et al (1975) A placebo-controlled study of lithium combined with neuroleptics in chronic schizophrenic patients. American Journal of Psychiatry, 132, 1315–1317.
Thompson, C. (1994) The use of high dose antipsychotic medication. British Journal of Psychiatry, 164, 448–458.
Van putten, T., Marshall, B. D., Liberman, R., et al (1993) Systematic dosage reduction in treatment resistant schizophrenic patients. Psychopharmacology Bulletin, 29, 315–320.
Vaughn, C. E. & Leff, J. P. (1976) The influence of family and social factors on the course of psychiatric illness. British Journal of Psychiatry, 129, 125–137.
Vaughn, C. E. & Leff, J. P. (1981) Patterns of emotional response in relatives of schizophrenic patients. Schizophrenia Bulletin, 7, 43–44.
Witheridge, T. F. (1991) The “Active ingredients” of Assertive Outreach. In New Directions for Mental Health Services, pp. 47–64. Josey-Bass.
Wolkowitz, O. M., Turetsky, N., Reus, V. I., et al (1992) Benzodiazepine augmentation of neuroleptics in treatment resistant schizophrenia. Psychopharmacology Bulletin, 28, 291–295.
Zastowny, T. R., Lehman, A. F., Cole, R. E., et al (1992) Family management of schizophrenia: a comparison of behavioural and supportive family treatment. Psychiatric Quarterly, 63, 159–186.